Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practice.

导出 LinkOut

翻译打印收藏纠错

第一作者： Saleh A,Alqahtani

第一单位： Liver Transplantation Unit, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.;Division Of Gastroenterology And Hepatology, Johns Hopkins University, Baltimore, USA.

作者： Saleh A,Alqahtani ^[1] ; Jörn M,Schattenberg ^[2]

作者单位： Liver Transplantation Unit, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.;Division Of Gastroenterology And Hepatology, Johns Hopkins University, Baltimore, USA. ^[1] Metabolic Liver Research Program, I. Department Of Medicine, University Medical Center, Mainz, Germany. ^[2]

关键词 Noninvasive tests advanced liver fibrosis cirrhosis diagnostic biomarker liver disease machine learning nonalcoholic fatty liver disease nonalcoholic steatohepatitis test accuracy

主题词人工智能(Artificial Intelligence);活组织检查(Biopsy);人类(Humans);肝硬化(Liver Cirrhosis)

DOI 10.1080/14737159.2021.1964958

PMID 34346799

发布时间 2022-04-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交